A total of 128 Streptococcus pneumoniae isolates that were susceptible to penicillin but resistant to non-β-lactam agents were isolated from young carriers in Greece and analyzed by antibiotic susceptibility testing, serotyping, restriction fragment end labeling (RFEL), and antibiotic resistance genotyping. The serotypes 6A/B (49%), 14 (14%), 19A/F (11%), 11A (9%), 23A/F (4%), 15B/C (2%), and 21 (2%) were most prevalent in this collection. Of the isolates, 65% were erythromycin resistant, while the remaining isolates were tetracycline and/or trimethoprim-sulfamethoxazole resistant. Fifty-nine distinct RFEL types were identified. Twenty different RFEL clusters, harboring 2 to 19 strains each, accounted for 76% of all strains. Confirmatory multilocus sequence typing analysis of the genetic clusters showed the presence of three international clones (Tennessee23F-4, England14-9, and Greece6B-22) representing 30% of the isolates. The erm(B) gene was present in 70% of the erythromycin-resistant isolates, whereas 18 and 8% contained the mef(A) and mef(E) genes, respectively. The pneumococci representing erm(B), erm(A), and mef genes belonged to distinct genetic clusters. In total, 45% of all isolates were tetracycline resistant. Ninety-six percent of these isolates contained the tet(M) gene. In conclusion, penicillin-susceptible pneumococci resistant to non-β-lactams are a genetically heterogeneous group displaying a variety of genotypes, resistance markers, and serotypes. This suggests that multiple genetic events lead to non-β-lactam-resistant pneumococci in Greece. Importantly, most of these genotypes are capable of disseminating within the community.

doi.org/10.1128/JCM.41.12.5633-5639.2003, hdl.handle.net/1765/56824
Journal of Clinical Microbiology
Department of Pediatrics

Bogaert, D., Hermans, P., Grivea, I. N., Katopodis, G. S., Mitchell, T. J., Sluijter, M., … Syrogiannopoulos, G. A. (2003). Molecular Epidemiology of Penicillin-Susceptible Non-β -Lactam-Resistant Streptococcus pneumoniae Isolates from Greek Children. Journal of Clinical Microbiology, 41(12), 5633–5639. doi:10.1128/JCM.41.12.5633-5639.2003